Discover how a genetic variant in C1GalT1 gene increases susceptibility to IgA nephropathy, a common kidney disease, through impaired glycosylation of IgA antibodies.
Groundbreaking research reveals how proteinuria and AOPP biomarkers can predict IgA nephropathy progression with remarkable accuracy.